Clinical Trials for Cancer Type: Other

12 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
2014-1503 Use of Portable Diffuse Optical Spectroscopy Technologies for Non-Invasive Hemodynamic Evaluation of Trauma/Critically Care Patients Open
2015-2390 A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients with Chronic Motor Deficit from Traumatic Brain Injury (TBI) Open
2016-2778 A Phase IIA, Multi-Center, Randomized, Single-Blind, Placebo-Controlled, Crossover Study To Assess The Safety, Tolerability, And Preliminary Efficacy Of A Single Intravenous Dose of Allogeneic Human Mesenchymal Stem Cells To Subjects With Mild to Moderate Dementia Due to Alzheimer's Disease (Protocol: STEM105-M-AD Date: May 21, 2015) Open
2016-2972 PLEGRIDY® (peginterferon ß 1a) Real World effectiveness and Safety Observational Program POP Open
2016-2975 The Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study will establish an open-label, longitudinal cohort study to assess the impact of amyloid PET on patient outcomes. Open
2016-3135 An Assessment of Humacyte's Human Acellular Vessel in Patients Needing Renal Replacement Therapy: A Comparison with ePTFE Grafts as Conduits for Hemodialysis (HUMANITY) Open
2016-3241 An Extension Study of JC-01 Evaluating Long-Term Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects with Retinitis Pigmentosa (RP) Open
2017-3605 WIRB Reliance #29: A Randomized, Double-Blind, Active Comparator-Controlled, Crossover Study to Assess the Capacity of Delayed-Release Prednisone (RAYOS®) Compared to Immediate-Release Prednisone to Improve Fatigue and Control Morning Symptoms in Subjects with Generalized Systemic Lupus Erythematosus Open
2017-3643 Randomized, Double blind, Active Control Study of the Safety and Efficacy of PRX-102 compared to Agalsidase Beta on Renal Function in Patients with Fabry Disease Previously Treated With Agalsidase Beta Open
2017-3807 A Phase 3 Study to Compare the Efficacy and Safety of Humacyte’s Human Acellular Vessel with that of an Autologous Arteriovenous Fistula in Subjects with End-Stage Renal Disease Open
2017-3818 A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER STUDY TO EVALUATE EFFICACY AND SAFETY OF REPEATED ADMINISTRATIONS OF NUROWN® (AUTOLOGOUS MESENCHYMAL STEM CELLS SECRETING NEUROTROPHIC FACTORS) IN PARTICIPANTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) Open
245685 Boeing Takes Off: Employee Weight Loss Program Open